Advances in infections and wound healing for the diabetic foot: The die is cast

International Journal of Lower Extremity Wounds

Volumn 12, Issue 2, 2013, Pages 83-86

  Papanas, Nikolaos ^a   Mani, Raj ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CYTOKINE; DAPTOMYCIN; GELATINASE B; INTERLEUKIN 6; LINEZOLID; PENICILLIN DERIVATIVE; PROCALCITONIN; PROTEINASE; QUINOLONE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VANCOMYCIN;

AMPUTATION; ANTIBIOTIC THERAPY; BAROTRAUMA; DIABETIC FOOT; FOLLOW UP; HEREDITY; HUMAN; HYPERBARIC OXYGEN; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OSTEOMYELITIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEIZURE; VACUUM ASSISTED CLOSURE; WOUND FLUID; WOUND HEALING; WOUND INFECTION;

DIABETIC FOOT; HUMANS; WOUND HEALING; WOUND INFECTION;

EID: 84879341609     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734613490507     Document Type: Review

References (40)

1. Papanas N, Lazarides MK. Diabetic foot amputations in Greece: where do we go from here?. Int J Low Extrem Wounds. 2011 ; 10: 4-5
2. Papanas N, Maltezos E, Edmonds M. Salvation of the diabetic foot: still a quest for the Holy Grail?. Vasa. 2011 ; 40: 267-269
3. Boulton AJ. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev. 2008 ; 24: S3 - S6
4. Lipsky BA, Peters EJ, Berendt AR, et al. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev. 2012 ; 28: 234-235
5. Macías Hernández AE, Alvarez JA, Cabeza de, Vaca F, et al. Microbiology of the diabetic foot: is the swab culture useful?. Gac Med Mex. 2011 ; 147: 117-124
6. Tiwari S, Pratyush DD, Dwivedi A, Gupta SK, Rai M, Singh SK. Microbiological and clinical characteristics of diabetic foot infections in northern India. J Infect Dev Ctries. 2012 ; 6: 329-332
7. Demetriou M, Papanas N, Panopoulou M, Papatheodorou K, Bounovas A, Maltezos E. Tissue and swab culture in diabetic foot infections: neuropathic vs. neuroischaemic ulcers. Int J Low Extrem Wounds. 2013 ; 12: 87-93
8. Byren I, Peters EJ, Hoey C, Berendt A, Lipsky BA. Pharmacotherapy of diabetic foot osteomyelitis. Expert Opin Pharmacother. 2009 ; 10: 3033-3047
9. Michail M, Jude E, Liaskos C, et al. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds. 2013 ; 12: 94-99
10. Dinh T, Snyder G, Veves A. Current techniques to detect foot infection in the diabetic patient. Int J Low Extrem Wounds. 2010 ; 9: 24-30
11. Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008 ; 47: 519-527
12. Lobmann R, Schultz G, Lehnert H. Proteases and diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care. 2006 ; 28: 461-471
13. Ambrosch A, Halevy D, Fwity B, Brin T, Lobmann R. Effect of daptomycin on local interleukin-6 (IL-6), matrix metalloproteinase-9 (MMP-9) and metallopeptidase inhibitor 1 (TIMP-1) in patients with MRSA-infected diabetic foot. Int J Low Extrem Wounds. 2013 ; 12: 100-105
14. Ambrosch A, Lobmann R, Pott A, Preissler J. IL-6 concentrations rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation. Int Wound J. 2008 ; 5: 99-106
15. Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012 ; 61: 2937-2947
16. Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with protease absorbent dressing. J Diabetes Complications. 2006 ; 20: 329-335
17. Davis SL, Rybak MJ, Amjad M, Kaatz GW, McKinnon PS. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2006 ; 27: 1025-1031
18. Feng S-H, Chu Y-J, Wang P-H, Jun X, Min D, Li X-M, et al. Risk factors and gene type for infections of MRSA in diabetic foot patients in Tian Jin of China. Int J Low Extrem Wounds. 2013 ; 12: 106-112
19. Löffler MW, Schuster H, Bühler S, Beckert S. Wound fluid in diabetic foot ulcerations - more than just an undefined soup?. Int J Low Extrem Wounds. 2013 ; 12: 113-129
20. Schmohl M, Beckert S, Joos TO, Königsrainer A, Schneiderhan-Marra N, Löffler MW. Superficial wound swabbing: a novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations. Diabetes Care. 2012 ; 35: 2113-2120
21. Löffler M, Zieker D, Weinreich J, et al. Wound fluid lactate concentration: a helpful marker for diagnosing soft-tissue infection in diabetic foot ulcers? Preliminary findings. Diabet Med. 2011 ; 28: 175-178
22. Aragón-Sánchez J. Treatment of diabetic foot osteomyelitis: a surgical critique. Int J Low Extrem Wounds. 2010 ; 9: 37-59
23. Aragón-Sánchez J.. Seminar review: a review of the basis of surgical treatment of diabetic foot infections ; 2011 ; 2011. 33.
24. Aragón-Sánchez J. Evidences and controversies about recurrence of diabetic foot osteomyelitis: a personal view and an illustrated guide for understanding. Int J Low Extrem Wounds. 2012 ; 11: 88-106
25. Aragón-Sánchez J, Lázaro-Martínez JL, Quintana-Marrero Y, et al. Super-oxidized solution (Dermacyn Wound Care) as adjuvant treatment in the postoperative management of complicated diabetic foot osteomyelitis: preliminary experience in a specialized department. Int J Low Extrem Wounds. 2013 ; 12: 130-137
26. Georgakarakos E, Charalampidis D, Kakagia D, Georgiadis GS, Lazarides MK, Papanas N. Current Achievements With Topical Negative Pressure to Improve Wound Healing in Dehiscent Ischemic Stumps of Diabetic Patients: A Case Series.. Int J Low Extrem Wounds. 2013 ; 12: 138-145
27. Schintler MV. Negative pressure therapy: theory and practice. Diabetes Metab Res Rev. 2012 ; 28: 72-77
28. Aragón-Sánchez J, Lázaro-Martínez JL, Molinés-Barroso R, García Álvarez Y, Quintana-Marrero Y, Hernández-Herrero MJ. Revision surgery for diabetic foot infections: giving another chance to the patient. Int J Low Extrem Wounds. 2013 ; 12: 146-151
29. Aragón-Sánchez J, Quintana-Marrero Y, Lázaro- Martínez JL, et al. Necrotizing soft-tissue infections in the feet of patients with diabetes: outcome of surgical treatment and factors associated with limb loss and mortality. Int J Low Extrem Wounds. 2009 ; 8: 141-146
30. Löndahl M. Hyperbaric oxygen therapy as adjunctive treatment of diabetic foot ulcers. Int J Low Extrem Wounds. 2013 ; 12: 152-157
31. Tiaka EK, Papanas N, Manolakis AC, Maltezos E. The role of hyperbaric oxygen in the treatment of diabetic foot ulcers. Angiology. 2012 ; 63: 302-314
32. Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010 ; 33: 998-1003
33. Löndahl M, Katzman P, Hammarlund C, Nilsson A, Landin-Olsson M. Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers. Diabetologia. 2011 ; 54: 65-68
34. Viswanathan V, Rao NV. Managing diabetic foot infection in India. Int J Low Extrem Wounds. 2013 ; 12: 158-166
35. Papanas N, Maltezos E. Polyherbal formulation as a therapeutic option to improve wound healing in the diabetic foot. Indian J Med Res. 2011 ; 134: 146-147
36. Morona JK, Buckley ES, Jones S, Reddin EA, Merlin TL. Comparison of the clinical effectiveness of different off-loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2013 ; 29: 183-193
37. Antonoglou C, Papanas N, Maltezos E. Lipid-lowering therapy in the diabetic foot: seeing the whole iceberg and not just the tip. Curr Vasc Pharmacol. 2012 ;:
38. Papanas N, Maltezos E. Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?. Int J Low Extrem Wounds. 2007 ; 6: 37-53
39. Papanas N, Maltezos E, Edmonds M. The diabetic foot: a plea for the elementary?. Acta Diabetol. 2006 ; 43: 152-153
40. Edmonds M. Modern treatment of infection and ischaemia to reduce major amputation in the diabetic foot. Curr Pharm Des. 2012: